Investment Q&A

Q: Hi team. I was fortunate to add to my Nvdia position at $219 a couple of weeks ago. Nvdia has now grown to 7% of my investment portfolio (stocks) and 6% of my total portfolio. I know you can’t get specific with weightings. I do see you typically trim your balance model portfolio around 8% when a winner runs.

Thoughts on how you decide to trim a winner and when?

Q: Hi,

CP seems to be not only holdings it's own, but trading at 52 week highs. All this while it's in a labour dispute with its union.

I would have thought that it's share price would fall with a labour dispute.

Robert

Q: Hi 5i I just sold some of my Nutrient to bring my holdings back to 6%. I am looking for suggestions for a replacement, in the material sector. I am a income investor

Q: I have held IVN since about $3. Closed today at $11.56. Given the size of their recently producing copper mine. Robert Friedland, Co-chair. Their rhodium, palladium. gold, platinum and nickel reserves I hope to hold this for a long time in spite of being situated in DRC. I should add I hold teck.b and Freeport as well for copper. I am happy with Ivanho as smaller copper producer. But am thinking of future for their other materials as listed.

What risks do you see in IVN?

Thank you, Mike

Q: Hi there, both companies have seen drops in their price. Is there any reason for their decline ?, 5i mentioned that on March 8 that it was safe to buy SPB, is still the case ?, Is it prudent o BDY now ?
thanks

Q: Can you list some of your favourite Canadian stocks that are eligible for the Canadian tax credit that yield over 4%? I am building a dividend portfolio and have the banks, ENB, PPB, SLF.

Thank you!

Q: Peter; With the huge number of refugees flooding Europe could this be bullish for ERE.UN? Thanks.
Rod

Q: Hi Everyone! What do you think of Warren Buffett’s pending purchase of Alleghany? It is my impression that a certain portion will be held in the Berkshire B fund which I already own. Would it be worthwhile to purchase a few shares of Alleghany separately?? Cheers, Tamara

Q: Hi, could I please have your opinion on the long end of the yield curve. The consensus seems to be that economic growth is starting to slow, inflation is increasing but may moderate in the second half but remain sticky and that the Fed may make a policy mistake by over tightening. To date the yield curve has steepened, short and long yields have increased, shorts more than longs. How might you see this playing out going forward. Do you think the long end of the curve presents an opportunity at this point? I am considering long perpetual preferreds which have also corrected but offer more generous tax favoured income (around 5%) than long bonds? Many thanks.

Q: Hello, Recently I had watched a few YouTube videos on Ray Dalio’s new book called the New World Order. I know there is always something to worry about, but, is this something an investor should worry about in the next decade to come ? Basically, the book is about how a new reserve currency will replace the US dollar as the reserve currency. Have you guys spent any time thinking about this as an Canadian investor or what the implications might mean if he is correct ?

Q: If I purchase GoEasy shares today (March 22 2022) will I receive the next dividend? Is the Ex Dividend date March 23, meaning if purchased on March 23 or later I will not receive the next dividend?
Thank you

Q: What would your bond ETF pick be for a 2 year holding period? I have been using XSB and CLF.

Q: According to a G&M article on treat of stagflation, XSB is not a good choice of invest re 40-60 portfolio.
Assuming you agree with this article what would be your top 3 or 4 investment to replace XSB ?

Q: I would like to add 5 or 6 Canadian companies to my portfolio that pay a decent dividend (3%+) and distribute monthly. I'm hoping that you can suggest some companies that fit the bill and you respect for their high quality, leadership and ability to whether the noise created by events such as we are currently experiecing. Thanks in advance for you continued respected advice.

Q: I own Dollarama shares.

If China in sanctioned by the West for supporting Russia would this leave companies like Dollarama vulnerable, as they source lots of Chinese products for their stores?

Thanks

Kim

Q: What is your view on Verisk (VRSK)

Q: Could you give me your opinion on the 2 stocks mentioned above. If picking one of the two, which would you prefer?
Thanks.

Q: Do you think Mr. Buffett would ever try to buy ENB?

Q: Good morning 5i

I am wavering between these two. I already own some abbivie. But I hesitate because it has shot up recently. I know you favour it. But I have seen several people lately, today Brian Acre, leaning towards bmy. Here is the reasoning of one such person:

The company has a strong pipeline of new drugs, but also a lot of patent expirations for its big existing drugs coming up, which means the company has to effectively rotate its portfolio of revenue-producing drugs in the coming years. To offset that risk, it is priced very cheaply, with a single-digit price/earnings ratio and a solid dividend yield. I think the current price offers a good accumulation zone.

I am wondering about your different approaches. Would it be that you favour growth more and they are looking for safe income?
Thanks as always

Q: I was wondering if you could provide any commentary on the newly spun-out company, ZImVie (formerly from Zimmer Biomet). I am familiar with their dental products - they are quite good, and focus primarily on the implant space (including implant fixtures, prosthetic components for tooth replacement and bone regeneration materials), rather than a more diversified product line throughout the dental space. I have spoken to a representative from the company, and my limited understanding is that it seems likelier that they plan to stay focused in this segment of dental health for the foreseeable future.

My question would be as follows: given the limited amount of time they have existed as a stand-alone company, can enough be gleaned from what is publicly available to make an informed decision regarding their longer-term prospects? At this point, I only have the worm’s-eye view (I use their products and like them, as well as their clinical support system), and I could really use a bird’s-eye vantage point. Thanks so much, and I look forward to reading you comments!